The MarketWatch News Department was not involved in the creation of this content. WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the ...

Use of platelet function testing during dual antiplatelet therapy, including a P2Y12 antagonist, in acute coronary syndromes does not improve clinical outcomes. Researchers at King's College London ...

Results of the TRANSLATE-POPS Trial Presented at TCT 2013 SAN FRANCISCO, CA. – According to a new study of heart attack patients treated with percutaneous coronary intervention (PCI), free access to ...

ROME, ITALY — Monitoring platelet function and individualizing antiplatelet therapy did not improve outcomes for elderly ACS patients undergoing coronary stenting, results of the ANTARCTIC trial show ...

Prospective and sequential evaluation of homeostatic changes leading to thrombosis across COVID 19 disease severity spectrum are limited. In this prospective observational study, haemostasis was ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...

You may need an MPV test if you show symptoms that suggest an issue with your platelet size or number. An MPV test involves drawing a blood sample from a vein and typically takes less than five ...

WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the development of a first-in-class platelet function assay that measures phosphorylation of ...

PlateletDiagnostics, LLC (PlateletDx.com), founded by Harvard Medical School platelet biology leaders, announced the development of a first-in-class platelet function assay that measures ...